FDA decides against changing Medwatch forms
This article was originally published in Clinica
Executive Summary
The US FDA has decided not to alter its two adverse event reporting forms. The agency made the disclosure last week in a routine notice to the Office of Management and Budget which reviews every government proposal to collect private sector information.